SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition
Author:
Publisher
Elsevier BV
Subject
Urology
Reference23 articles.
1. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012
2. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy;Hirano;Eur Urol,2004
3. Changes in chromogranin a serum levels during endocrine therapy in metastatic prostate cancer patients;Sasaki;Eur Urol,2005
4. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets;Beltran;Cancer Discov,2011
5. The many faces of neuroendocrine differentiation in prostate cancer progression;Terry;Front Oncol,2014
Cited by 141 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PROX1 drives neuroendocrine plasticity and liver metastases in prostate cancer;Cancer Letters;2024-08
2. SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing;Journal of Hematology & Oncology;2024-07-30
3. Circular RNA in cancer;Nature Reviews Cancer;2024-07-29
4. ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer;Nucleic Acids Research;2024-06-27
5. Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST;Cell Death Discovery;2024-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3